Generation of a functional mammary gland from a single stem cell M Shackleton, F Vaillant, KJ Simpson, J Stingl, GK Smyth, ... Nature 439 (7072), 84-88, 2006 | 2535 | 2006 |
Efficient tumour formation by single human melanoma cells E Quintana, M Shackleton, MS Sabel, DR Fullen, TM Johnson, ... Nature 456 (7222), 593-598, 2008 | 2203 | 2008 |
Purification and unique properties of mammary epithelial stem cells J Stingl, P Eirew, I Ricketson, M Shackleton, F Vaillant, D Choi, HI Li, ... Nature 439 (7079), 993-997, 2006 | 1917 | 2006 |
Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1819* | 2020 |
Whole–genome characterization of chemoresistant ovarian cancer AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ... Nature 521 (7553), 489-494, 2015 | 1542 | 2015 |
Heterogeneity in cancer: cancer stem cells versus clonal evolution M Shackleton, E Quintana, ER Fearon, SJ Morrison Cell 138 (5), 822-829, 2009 | 1479 | 2009 |
Whole-genome landscapes of major melanoma subtypes NK Hayward, JS Wilmott, N Waddell, PA Johansson, MA Field, K Nones, ... Nature 545 (7653), 175-180, 2017 | 1326 | 2017 |
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation ML Asselin-Labat, KD Sutherland, H Barker, R Thomas, M Shackleton, ... Nature cell biology 9 (2), 201-209, 2007 | 972 | 2007 |
Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized E Quintana, M Shackleton, HR Foster, DR Fullen, MS Sabel, TM Johnson, ... Cancer cell 18 (5), 510-523, 2010 | 708 | 2010 |
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... Nature genetics 52 (3), 331-341, 2020 | 576 | 2020 |
Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans ID Davis, W Chen, H Jackson, P Parente, M Shackleton, W Hopkins, ... Proceedings of the National Academy of Sciences 101 (29), 10697-10702, 2004 | 540 | 2004 |
The mammary progenitor marker CD61/β3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis F Vaillant, ML Asselin-Labat, M Shackleton, NC Forrest, GJ Lindeman, ... Cancer research 68 (19), 7711-7717, 2008 | 405 | 2008 |
MDM4 is a key therapeutic target in cutaneous melanoma A Gembarska, F Luciani, C Fedele, EA Russell, M Dewaele, S Villar, ... Nature medicine 18 (8), 1239-1247, 2012 | 367 | 2012 |
Steroid hormone receptor status of mouse mammary stem cells ML Asselin-Labat, M Shackleton, J Stingl, F Vaillant, NC Forrest, ... Journal of the National Cancer Institute 98 (14), 1011-1014, 2006 | 352 | 2006 |
UV-associated mutations underlie the etiology of MCV-negative Merkel cell carcinomas SQ Wong, K Waldeck, IA Vergara, J Schröder, J Madore, JS Wilmott, ... Cancer research 75 (24), 5228-5234, 2015 | 344 | 2015 |
Normal stem cells and cancer stem cells: similar and different M Shackleton Seminars in cancer biology 20 (2), 85-92, 2010 | 228 | 2010 |
Antisense oligonucleotide–mediated MDM4 exon 6 skipping impairs tumor growth M Dewaele, T Tabaglio, K Willekens, M Bezzi, SX Teo, DHP Low, CM Koh, ... The Journal of clinical investigation 126 (1), 68-84, 2016 | 170 | 2016 |
Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli M Jefford, M Schnurr, T Toy, KA Masterman, A Shin, T Beecroft, TY Tai, ... Blood 102 (5), 1753-1763, 2003 | 160 | 2003 |
Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA L Tan, S Sandhu, RJ Lee, J Li, J Callahan, S Ftouni, N Dhomen, ... Annals of Oncology 30 (5), 804-814, 2019 | 145 | 2019 |
The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand M Shackleton, ID Davis, W Hopkins, H Jackson, N Dimopoulos, T Tai, ... Cancer Immunity 4 (1), 2004 | 142 | 2004 |